$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi

$efsi Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000088064120000046 Filed on May 11, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$9.107M	$8.593M
YoY Change	5.98%	14.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$258.0K	$231.0K
YoY Change	11.69%	-1.28%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$1.102M	$969.0K
YoY Change	13.73%	127.46%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$2.917M	$3.043M
YoY Change	-4.14%	0.93%
Income Tax	$476.0K	$472.0K
% Of Pretax Income	16.32%	15.51%
Net Earnings	$2.441M	$2.571M
YoY Change	-5.06%	1.26%
Net Earnings / Revenue	26.8%	29.92%
Basic Earnings Per Share	$0.71	$0.74
Diluted Earnings Per Share	$0.71	$0.74
COMMON SHARES
Basic Shares Outstanding	3.437M shares	3.458M shares
Diluted Shares Outstanding	3.437M

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$23.05M	$12.22M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$19.18M	$19.21M
YoY Change	-0.15%	-1.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$898.9M	$808.7M
YoY Change	11.15%	4.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$4.200M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$400.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.200M	$400.0K
YoY Change	950.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.900M	$9.700M
YoY Change	-49.48%	36.62%
Total Long-Term Liabilities	$4.900M	$9.700M
YoY Change	-49.48%	36.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.200M	$400.0K
Total Long-Term Liabilities	$4.900M	$9.700M
Total Liabilities	$799.1M	$717.5M
YoY Change	11.36%	3.57%
SHAREHOLDERS EQUITY
Retained Earnings	$76.46M	$70.33M
YoY Change	8.71%	8.89%
Common Stock	$8.466M	$8.604M
YoY Change	-1.6%	-0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$99.80M	$91.19M
YoY Change
Total Liabilities & Shareholders Equity	$898.9M	$808.7M
YoY Change	11.15%	4.23%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	$2.441M	$2.571M
YoY Change	-5.06%	1.26%
Depreciation, Depletion And Amortization	$258.0K	$231.0K
YoY Change	11.69%	-1.28%
Cash From Operating Activities	$1.897M	$2.025M
YoY Change	-6.32%	-123.59%
INVESTING ACTIVITIES
Capital Expenditures	$140.0K	$494.0K
YoY Change	-71.66%	274.24%
Acquisitions
YoY Change
Other Investing Activities	-$28.93M	-$9.730M
YoY Change	197.33%	-36.86%
Cash From Investing Activities	-$29.07M	-$10.22M
YoY Change	184.39%	-34.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	16.56M	$2.058M
YoY Change	704.47%	-90.41%
NET CHANGE
Cash From Operating Activities	1.897M	$2.025M
Cash From Investing Activities	-29.07M	-$10.22M
Cash From Financing Activities	16.56M	$2.058M
Net Change In Cash	-10.61M	-$6.138M
YoY Change	72.92%	130.41%
FREE CASH FLOW
Cash From Operating Activities	$1.897M	$2.025M
Capital Expenditures	$140.0K	$494.0K
Free Cash Flow	$1.757M	$1.531M
YoY Change	14.76%	-117.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000880641
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3409688	shares
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	EAGLE FINANCIAL SERVICES INC
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	efsi	Affordable Housing Tax Creditsand Other Tax Benefits Expectedto Be Received AffordableHousingTaxCreditsandOtherTaxBenefitsExpectedtoBeReceived	329000	USD
CY2019Q1	efsi	Amortization Of Intangible And Other Assets AmortizationOfIntangibleAndOtherAssets	58000	USD
CY2020Q1	efsi	Amortization Of Intangible And Other Assets AmortizationOfIntangibleAndOtherAssets	103000	USD
CY2019Q1	efsi	Atm Network Fees AtmNetworkFees	230000	USD
CY2020Q1	efsi	Atm Network Fees AtmNetworkFees	242000	USD
CY2019Q1	efsi	Bank Franchise Tax BankFranchiseTax	146000	USD
CY2020Q1	efsi	Bank Franchise Tax BankFranchiseTax	174000	USD
CY2019Q1	efsi	Changes In Shareholder Equity Retirement Of Common Stock ChangesInShareholderEquityRetirementOfCommonStock	-47000	USD
CY2020Q1	efsi	Changes In Shareholder Equity Retirement Of Common Stock ChangesInShareholderEquityRetirementOfCommonStock	-1116000	USD
CY2020Q1	efsi	Consolidated Financial Ownership Wholly Owned Subsidiary Percentage ConsolidatedFinancialOwnershipWhollyOwnedSubsidiaryPercentage	1.00
CY2019Q1	efsi	Dataprocessingfees Dataprocessingfees	240000	USD
CY2020Q1	efsi	Dataprocessingfees Dataprocessingfees	481000	USD
CY2020Q1	efsi	Deferred Compensation Arrangements Unrecognized Compensation Cost Related To Unvested Restricted Stock DeferredCompensationArrangementsUnrecognizedCompensationCostRelatedToUnvestedRestrictedStock	251000	USD
CY2019Q4	efsi	Financing Receivable Modifications Nonaccrual Numberof Contracts FinancingReceivableModificationsNonaccrualNumberofContracts	4
CY2020Q1	efsi	Financing Receivable Modifications Nonaccrual Numberof Contracts FinancingReceivableModificationsNonaccrualNumberofContracts	3
CY2019Q4	efsi	Financing Receivable Modifications Nonaccrual Recorded Investment FinancingReceivableModificationsNonaccrualRecordedInvestment	401000	USD
CY2020Q1	efsi	Financing Receivable Modifications Nonaccrual Recorded Investment FinancingReceivableModificationsNonaccrualRecordedInvestment	155000	USD
CY2019Q1	efsi	Financing Receivable Modifications Number Of Additional Contracts FinancingReceivableModificationsNumberOfAdditionalContracts	0
CY2020Q1	efsi	Financing Receivable Modifications Number Of Additional Contracts FinancingReceivableModificationsNumberOfAdditionalContracts	0
CY2019Q1	efsi	Gain Loss On Sale Of Bank Premises And Equipment GainLossOnSaleOfBankPremisesAndEquipment	120000	USD
CY2020Q1	efsi	Gain Loss On Sale Of Bank Premises And Equipment GainLossOnSaleOfBankPremisesAndEquipment	0	USD
CY2020Q1	efsi	Lessee Operating Lease Liability Payments Due After Year Six LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix	4020000	USD
CY2020Q1	efsi	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	311000	USD
CY2019Q4	efsi	Mortgage Loans In Process Of Foreclosure Number MortgageLoansInProcessOfForeclosureNumber	2
CY2020Q1	efsi	Mortgage Loans In Process Of Foreclosure Number MortgageLoansInProcessOfForeclosureNumber	0
CY2019Q1	efsi	Noninterest Income Fiduciary Activities NoninterestIncomeFiduciaryActivities	282000	USD
CY2020Q1	efsi	Noninterest Income Fiduciary Activities NoninterestIncomeFiduciaryActivities	297000	USD
CY2019Q1	efsi	Noninterest Income Other Service Chargesand Fees NoninterestIncomeOtherServiceChargesandFees	1071000	USD
CY2020Q1	efsi	Noninterest Income Other Service Chargesand Fees NoninterestIncomeOtherServiceChargesandFees	1104000	USD
CY2019Q1	efsi	Noninterest Income Service Chargeson Deposit Accounts NoninterestIncomeServiceChargesonDepositAccounts	285000	USD
CY2020Q1	efsi	Noninterest Income Service Chargeson Deposit Accounts NoninterestIncomeServiceChargesonDepositAccounts	284000	USD
CY2019Q1	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	450000	USD
CY2020Q1	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	749000	USD
CY2019Q1	efsi	Other Real Estate Gain On Foreclosure OtherRealEstateGainOnForeclosure	397000	USD
CY2019	efsi	Other Real Estate Gain On Foreclosure OtherRealEstateGainOnForeclosure	192000	USD
CY2020Q1	efsi	Other Real Estate Gain On Foreclosure OtherRealEstateGainOnForeclosure	132000	USD
CY2019Q4	efsi	Other Real Estate Gross OtherRealEstateGross	183000	USD
CY2020Q1	efsi	Other Real Estate Gross OtherRealEstateGross	442000	USD
CY2019Q1	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	0	USD
CY2020Q1	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	2000	USD
CY2019Q1	efsi	Paymentsfor Retirement Of Common Stock PaymentsforRetirementOfCommonStock	47000	USD
CY2020Q1	efsi	Paymentsfor Retirement Of Common Stock PaymentsforRetirementOfCommonStock	1116000	USD
CY2020Q1	efsi	Period Past Due Loan Considered Payment Default PeriodPastDueLoanConsideredPaymentDefault	P30D
CY2019Q4	efsi	Time Deposits250000or More TimeDeposits250000orMore	79104000	USD
CY2020Q1	efsi	Time Deposits250000or More TimeDeposits250000orMore	81727000	USD
CY2019Q4	efsi	Time Deposits Lessthan250000 TimeDepositsLessthan250000	59094000	USD
CY2020Q1	efsi	Time Deposits Lessthan250000 TimeDepositsLessthan250000	59087000	USD
CY2019Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-99000	USD
CY2020Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-145000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1553000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	137000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1482000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4298000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11406000	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10578000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	86000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	114000	USD
CY2019Q1	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	95000	USD
CY2020Q1	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	89000	USD
CY2019Q4	us-gaap	Amortization Method Qualified Affordable Housing Project Investments AmortizationMethodQualifiedAffordableHousingProjectInvestments	3000000	USD
CY2020Q1	us-gaap	Amortization Method Qualified Affordable Housing Project Investments AmortizationMethodQualifiedAffordableHousingProjectInvestments	2975000	USD
CY2019Q1	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	57000	USD
CY2020Q1	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	57000	USD
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2019Q4	us-gaap	Assets Assets	877320000	USD
CY2020Q1	us-gaap	Assets Assets	898877000	USD
CY2019Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	165003000	USD
CY2020Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	156391000	USD
CY2019Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	165003000	USD
CY2020Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	156391000	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2187000	USD
CY2020Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	5448000	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	365000	USD
CY2020Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	61000	USD
CY2019Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	163181000	USD
CY2020Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	151004000	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	49000	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	365000	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	61000	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	36293000	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	4874000	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	316000	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	61000	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	28102000	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	4874000	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	8191000	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2019Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	6000	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0	USD
CY2019Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	9000	USD
CY2019Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	28
CY2020Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	11
CY2019Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	10920000	USD
CY2020Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	10515000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	33659000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	23045000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18353000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12215000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33659000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23045000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6138000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10614000	USD
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.24
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.26
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3430103	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3406927	shares
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	8529000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	8466000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4261000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5257000	USD
CY2019Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-3000	USD
CY2020Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	0	USD
CY2019Q4	us-gaap	Deposits Domestic DepositsDomestic	771544000	USD
CY2020Q1	us-gaap	Deposits Domestic DepositsDomestic	789999000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	231000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	258000	USD
CY2019Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	16000	USD
CY2020Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	19000	USD
CY2019Q1	us-gaap	Dividends Common Stock DividendsCommonStock	830000	USD
CY2020Q1	us-gaap	Dividends Common Stock DividendsCommonStock	893000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.71
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.74
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2019Q1	us-gaap	Equipment Expense EquipmentExpense	202000	USD
CY2020Q1	us-gaap	Equipment Expense EquipmentExpense	232000	USD
CY2019Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	53000	USD
CY2020Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	0	USD
CY2019Q4	us-gaap	Federal Funds Sold FederalFundsSold	252000	USD
CY2020Q1	us-gaap	Federal Funds Sold FederalFundsSold	288000	USD
CY2018Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5456000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5685000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4973000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5387000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	4673000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	5106000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	300000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	281000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	45000	USD
CY2019	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	201000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	578000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	10000	USD
CY2019	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1313000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	67000	USD
CY2019Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	637804000	USD
CY2020Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	666648000	USD
CY2019Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	7403000	USD
CY2020Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	6299000	USD
CY2019	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	18
CY2020Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	17
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	3000000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	2700000	USD
CY2019Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	1
CY2019Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	641418000	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	663088000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	2185000	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	1697000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	3789000	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	9859000	USD
CY2019Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	120000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2019Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	0	USD
CY2020Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	132000	USD
CY2019	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	7685000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	6659000	USD
CY2019	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	301000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	58000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	7420000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	6327000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	300000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	281000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	8381000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	7228000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3043000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2917000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	472000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	476000	USD
CY2019Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2020Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	3751000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	549000	USD
CY2019Q1	us-gaap	Increase Decrease In Federal Funds Purchased IncreaseDecreaseInFederalFundsPurchased	1516000	USD
CY2020Q1	us-gaap	Increase Decrease In Federal Funds Purchased IncreaseDecreaseInFederalFundsPurchased	0	USD
CY2019Q1	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-1050000	USD
CY2020Q1	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-919000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Deposits IncreaseDecreaseInOtherDeposits	3714000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Deposits IncreaseDecreaseInOtherDeposits	15839000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	47000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	16000	USD
CY2019Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	621000	USD
CY2020Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	2616000	USD
CY2019Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	110000	USD
CY2020Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	120000	USD
CY2019Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	8593000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	9107000	USD
CY2019Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	7518000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	7939000	USD
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	364175000	USD
CY2020Q1	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	377677000	USD
CY2019Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	22487000	USD
CY2020Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	12242000	USD
CY2019Q4	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	154133000	USD
CY2020Q1	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	170566000	USD
CY2019Q4	us-gaap	Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW	102337000	USD
CY2020Q1	us-gaap	Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW	95361000	USD
CY2019Q4	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	107705000	USD
CY2020Q1	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	111750000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	969000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	1102000	USD
CY2019Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	944000	USD
CY2020Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	1102000	USD
CY2019Q1	us-gaap	Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	25000	USD
CY2020Q1	us-gaap	Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	0	USD
CY2019Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	31000	USD
CY2020Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	86000	USD
CY2019Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	7430000	USD
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	8102000	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7624000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8005000	USD
CY2019Q1	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	1000	USD
CY2020Q1	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	1000	USD
CY2019Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	242000	USD
CY2020Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	167000	USD
CY2019Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	785000	USD
CY2020Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	895000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	954000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	1109000	USD
CY2019Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3542000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4088000	USD
CY2019Q1	us-gaap	Lease Cost LeaseCost	69000	USD
CY2020Q1	us-gaap	Lease Cost LeaseCost	78000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5865000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	328000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	325000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	323000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	320000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	238000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1670000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	780994000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	799078000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	877320000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	898877000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	4973000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	5387000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Deferred Income LoansAndLeasesReceivableDeferredIncome	447000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Deferred Income LoansAndLeasesReceivableDeferredIncome	-1085000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	645207000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	672947000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	644760000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	674032000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	639787000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	668645000	USD
CY2019Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	218000	USD
CY2020Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	205000	USD
CY2019Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	334000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2058000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16556000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10221000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29067000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2025000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1897000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	2571000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	2441000	USD
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	269171000	USD
CY2020Q1	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	271508000	USD
CY2019Q1	us-gaap	Noninterest Expense NoninterestExpense	6231000	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	6875000	USD
CY2019Q1	us-gaap	Noninterest Income NoninterestIncome	1844000	USD
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	1690000	USD
CY2019Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	89000	USD
CY2020Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	5000	USD
CY2019Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	635666000	USD
CY2020Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	659024000	USD
CY2019Q1	us-gaap	Occupancy Net OccupancyNet	428000	USD
CY2020Q1	us-gaap	Occupancy Net OccupancyNet	395000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	65000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	74000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3680000	USD
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4195000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	50000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	58000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3618000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4127000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0362
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0334
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P20Y
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P18Y
CY2019Q4	us-gaap	Other Assets OtherAssets	18194000	USD
CY2020Q1	us-gaap	Other Assets OtherAssets	29907000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	2137000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	3565000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1690000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2816000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	1000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1690000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2816000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	450000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	749000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	9450000	USD
CY2020Q1	us-gaap	Other Liabilities OtherLiabilities	9079000	USD
CY2019Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	648000	USD
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	682000	USD
CY2018Q4	us-gaap	Other Real Estate OtherRealEstate	106000	USD
CY2019Q1	us-gaap	Other Real Estate OtherRealEstate	503000	USD
CY2019Q4	us-gaap	Other Real Estate OtherRealEstate	183000	USD
CY2020Q1	us-gaap	Other Real Estate OtherRealEstate	442000	USD
CY2019Q1	us-gaap	Other Real Estate Additions OtherRealEstateAdditions	0	USD
CY2019	us-gaap	Other Real Estate Additions OtherRealEstateAdditions	1151000	USD
CY2020Q1	us-gaap	Other Real Estate Additions OtherRealEstateAdditions	310000	USD
CY2019Q1	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	0	USD
CY2019	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	1266000	USD
CY2020Q1	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	183000	USD
CY2019Q1	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	0	USD
CY2019	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	0	USD
CY2020Q1	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	0	USD
CY2019Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	12346000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	29071000	USD
CY2019Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	714000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	783000	USD
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	3888000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2019Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	0	USD
CY2020Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	12000000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	494000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	140000	USD
CY2019Q1	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	0	USD
CY2020Q1	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	71000	USD
CY2020Q1	us-gaap	Pledged Financial Instruments Not Separately Reported Securities Pledged PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged	2900000	USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	10
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	10
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2431000	USD
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	12032000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	3818000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	0	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	183000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	258000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2019Q1	us-gaap	Professional Fees ProfessionalFees	385000	USD
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	354000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19297000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19179000	USD
CY2019Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	194000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-97000	USD
CY2019Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	194000	USD
CY2019	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	629000	USD
CY2020Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-97000	USD
CY2019Q4	us-gaap	Qualified Affordable Housing Project Investments Commitment QualifiedAffordableHousingProjectInvestmentsCommitment	800000	USD
CY2020Q1	us-gaap	Qualified Affordable Housing Project Investments Commitment QualifiedAffordableHousingProjectInvestmentsCommitment	766000	USD
CY2019Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	183000	USD
CY2020Q1	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	442000	USD
CY2019Q4	us-gaap	Real Estate Owned Valuation Allowance RealEstateOwnedValuationAllowance	0	USD
CY2020Q1	us-gaap	Real Estate Owned Valuation Allowance RealEstateOwnedValuationAllowance	0	USD
CY2019Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-3000	USD
CY2020Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	0	USD
CY2019Q4	us-gaap	Restricted Investments RestrictedInvestments	1197000	USD
CY2020Q1	us-gaap	Restricted Investments RestrictedInvestments	1268000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	74909000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	76457000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	86000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	114000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.00
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.00
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	11450	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	11925	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	30.51
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	31.05
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	16701	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	18151	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	18488	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	20480	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	29.72
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	30.40
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	30.39
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	30.90
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	10000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	9933	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	29.30
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	30.13
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	500000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2019Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	USD
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	USD
CY2019Q1	us-gaap	Stock Issued1 StockIssued1	116000	USD
CY2020Q1	us-gaap	Stock Issued1 StockIssued1	110000	USD
CY2019Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	3685	shares
CY2020Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	3514	shares
CY2019Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	10000	shares
CY2020Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	9933	shares
CY2019Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	116000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	111000	USD
CY2019Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	1500	shares
CY2020Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	38614	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	87599000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	91185000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	96326000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	99799000	USD
CY2019Q1	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	29000	USD
CY2020Q1	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	32000	USD
CY2019Q4	us-gaap	Time Deposits TimeDeposits	138198000	USD
CY2020Q1	us-gaap	Time Deposits TimeDeposits	140814000	USD
CY2019Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	0	USD
CY2020Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	310000	USD
CY2019Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2140000	USD
CY2020Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3565000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3458213	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3437085	shares
CY2020Q1	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 13. Recent Accounting Pronouncements and Other Authoritative Guidance</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The amendments in this ASU, among other things, require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. In addition, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. At the FASB’s October 16, 2019 meeting, the Board affirmed its decision to amend the effective date of this ASU for many companies.   Public business entities that are SEC filers, excluding those meeting the smaller reporting company definition, will retain the initial required implementation date of fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  All other entities will be required to apply the guidance for fiscal years, and interim periods within those years, beginning after December 15, 2022. The Company is currently assessing the impact that ASU 2016-13 will have on its consolidated financial statements.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">The Company formed a CECL committee during 2016 which continues to meet weekly to address the compliance requirements. Historic loan data has been gathered and reviewed for completeness and accuracy. In addition, the committee has selected a third-party that is assisting in calculating the financial impact of ASU 2016-13 and anticipates running parallel allowance models under the current and new standard in advance of the required implementation date.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes.” The ASU is expected to reduce cost and complexity related to the accounting for income taxes by removing specific exceptions to general principles in Topic 740 (eliminating the need for an organization to analyze whether certain exceptions apply in a given period) and improving financial statement preparers’ application of certain income tax-related guidance. This ASU is part of the FASB’s simplification initiative to make narrow-scope simplifications and improvements to accounting standards through a series of short-term projects. For public business entities, the amendments are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently assessing the impact that ASU 2019-12 will have on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2020, the FASB issued ASU 2020-01, “Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The ASU is based on a consensus of the Emerging Issues Task Force and is expected to increase comparability in accounting for these transactions. ASU 2016-01 made targeted improvements to accounting for financial instruments, including providing an entity the ability to measure certain equity securities without a readily determinable fair value at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Among other topics, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting. For public business entities, the amendments in the ASU are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-01 to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” These amendments provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. It is intended to help stakeholders during the global market-wide reference rate transition period. The guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is working to identify loans that are directly or indirectly influenced by LIBOR. The Company is assessing ASU 2020-04 and its impact on the Company’s transition away from LIBOR for its loans.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 12, 2020, the SEC finalized amendments to its “accelerated filer” and “large accelerated filer” definitions. The amendments increase the threshold criteria for meeting these filer classifications and are effective on April 27, 2020. Any changes in filer status are to be applied beginning with the filer’s first annual report filed with the SEC subsequent to the effective date.  Prior to these changes, the Company was required to comply with section 404(b) of the Sarbanes Oxley Act concerning auditor attestation over internal control over financial reporting as an “accelerated filer” as it had more than $75 million but less than $700 million in public float at the end of the Company’s most recent second quarter</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;">  The rule change revises the definition of “accelerated filers” to exclude entities with public float of less than $700 million and less than $100 million in annual revenues.  The Company expects that, under this revised definition, it will no longer be considered an accelerated filer.  If the Company’s annual revenues exceed $100 million, its category will change back to an “accelerated filer”.  The classifications of “accelerated filer” and “large accelerated filer” require a public company to obtain an auditor attestation concerning the effectiveness of internal control over financial reporting (ICFR) and include the opinion on ICFR in its annual report on Form 10-K.  Non-accelerated filers also have additional time to file quarterly and annual financial statements.  All public companies are required to obtain and file annual financial statement audits, as well as provide management’s assertion on effectiveness of internal control over financial reporting, but the external auditor attestation of internal control over financial reporting is not required for non-accelerated filers. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2020, various regulatory agencies, including the Board of Governors of the Federal Reserve System and the Federal Deposit Insurance Corporation, (“the agencies”) issued an interagency statement on loan modifications and reporting for financial institutions working with customers affected by the Coronavirus. The interagency statement was effective immediately and impacted accounting for loan modifications. Under Accounting Standards Codification 310-40, “Receivables - Troubled Debt Restructurings by Creditors,” (“ASC 310-40”), a restructuring of debt constitutes a troubled debt restructuring (“TDR”) if the creditor, for economic or legal reasons related to the debtor’s financial difficulties, grants a concession to the debtor that it would not otherwise consider. The agencies confirmed with the staff of the FASB that short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief, are not to be considered TDRs. This includes short-term (e.g., six months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. Borrowers considered current are those that are less than 30 days past due on their contractual payments at the time a modification program is implemented. This interagency guidance is expected to have an impact on the Company’s financial statements; however, this impact cannot be quantified at this time.</font></div></div>

Files In Submission

Name	View Source	Status
0000880641-20-000046-index-headers.html	Edgar Link	pending
0000880641-20-000046-index.html	Edgar Link	pending
0000880641-20-000046.txt	Edgar Link	pending
0000880641-20-000046-xbrl.zip	Edgar Link	pending
efsi-20200331.xml	Edgar Link	completed
efsi-20200331.xsd	Edgar Link	pending
efsi-20200331exhibit311.htm	Edgar Link	pending
efsi-20200331exhibit312.htm	Edgar Link	pending
efsi-20200331exhibit321.htm	Edgar Link	pending
efsi-20200331x10q.htm	Edgar Link	pending
efsi-20200331_cal.xml	Edgar Link	unprocessable
efsi-20200331_def.xml	Edgar Link	unprocessable
efsi-20200331_lab.xml	Edgar Link	unprocessable
efsi-20200331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi

2020 Q1 Form 10-Q Financial Statement

#000088064120000046 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EFSI EAGLE FINANCIAL SERVICES INC Stock $efsi

2020 Q1 Form 10-Q Financial Statement

#000088064120000046 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi